AffiAB® Anti-Hu CD263 FITC [TRAIL-R3-02]

https://www.affiab.com/web/image/product.template/109909/image_1920?unique=d31c23b
(0 review)

CAT# AFG-EXB-1241
Size: 100 Tests

333.50 333.5 USD 333.50

333.50

For Price Contact info@affigen.com

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Overview

TRAIL-R3 (CD263, TR3, DcR1, LIT, TRID), expressed mainly on neutrophils, belongs to receptors of TRAIL, a TNF-like membrane cytotoxic protein that induces apoptosis in many tumour cells, but not in normal cells. TRAIL-R3, however, is a GPI-anchored protein that lacks cytoplasmic death domain, thus it is unable to induce apoptosis and serves as a negative regulator of apoptotic signaling by competing for binding of TRAIL with death receptor 5 (DR5) .


Specificity:

The antibody TRAIL-R3-02 reacts with TRAIL-R3, a 35 kDa GPI-anchored extracellular membrane protein expressed mainly on neutrophils.

Antigen

CD263

Clone

TRAIL-R3-02

Species Reactivity

Human

Negative Species

N/A

Isotype

Mouse IgG1

Immunogen

TRAIL-R3-hIgGhc fusion protein

Application

FC (QC tested)

Regulatory status

RUO

Concentration

0.1 mg/ml

Format

FITC

Storage / Stability

Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.

Storage Buffer

Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide